You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Fulcrum Biometrics' Plan for Research and Development of WS-BD Conformant Handheld Fingerprint Sensor
SBC: Fulcrum Biometrics, LLC Topic: N/ATrusted biometric validation of individual identities has never been more important. Several contributing factors are the increase in global terrorism, identity theft and the increase in legislation which are driving the accelerated adoption of biometric technology. Unfortunately, the biometrics industry has not actively responded to the changing market conditions being driven by the explosion in ...
SBIR Phase I 2012 Department of CommerceNational Institute of Standards and Technology -
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine
SBC: NORWELL, INC. Topic: NIAIDDESCRIPTION (provided by applicant): The final objective of this Phase II SBIR is to complete preclinical studies of a trivalent adenoviral vaccine against plague in preparation for human clinical trials. The plague vaccine project was selected in responseto the growing concern surrounding the organism's possible use in a terrorism event. The NIAID and CDC, in response to this threat, has cla ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of RLIP76 protein as a Radiation Countermeasure
SBC: TERAPIO Topic: NIAIDDESCRIPTION (provided by applicant): There remains a critical need for medicines that can counteract the toxic effects of radiation exposure. Terapio is developing a recombinant protein, RLIP76, for use as a radioprotectant for workers, military personnel, or civilians that are either in imminent danger of radiation exposure, or have already been exposed. In research carried out at the Unive ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure
SBC: Chrysalis BioTherapeutics, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): With recent radiation release from reactors in Japan and increasing probability of nuclear detonation somewhere in the world, there is a critical need for development of effective medicinal counter-measures that can bedelivered after exposure to prevent radiation-induced mortality. Adding to this need, mortality increases significantly when radiation is combine ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Reduction of Dietary Oxalate
SBC: CAPTOZYME LLC Topic: NCCAMDESCRIPTION (provided by applicant): Kidney stones are a common and painful human health care problem worldwide. Of all stones developed approximately 75% are composed of calcium oxalate. Urinary oxalate is regarded as a driving force for calcium oxalate stone formation, and absorption of dietary oxalate contributes to 10-70% of urinary oxalate. In fact, roughly 2.4 million Americans (0.75% of the ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Flat Panel X-ray Sources for Digital Breast Tomosynthesis System
SBC: STELLARRAY INC Topic: NCIDESCRIPTION (provided by applicant): X-ray mammography continues to be the primary tool for breast cancer screening and plays an important role in the diagnosis and management of breast cancer. However, the difficulty in resolving overlapping structures ina 2-D projection image leads to reduced sensitivity. A number of research groups and companies are developing dedicated breast tomographic syste ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
3D Tracking for OCT Image Fusion in Gynecological Diagnosis
SBC: Biotex, Inc. Topic: NCIDESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to continue development of an exciting platform based on integration of optical coherence tomography acquisition with real-time 3D spatial localization. In Phase I, in the context of gynecological diagnostic imaging, we demonstrated hardware and software for prototype image fusion between colposcopic/intravaginal imagin ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of Wnt Pathway Inhibitors for Colorectal Cancer
SBC: Stemsynergy Therapeutic Topic: NCIDESCRIPTION (provided by applicant): StemSynergy Therapeutics Inc. (SSTI) is a biopharmaceutical company focused on the discovery, development, and commercialization of drugs that target pathways fundamental to stem cells and cancer stem cells. The WorldHealth Organization estimates that over 12 million cases of cancer were diagnosed in 2007 and that nearly 8 million cancer patients will die of t ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Quick-Set Material-Phase II
SBC: PRIMUS CONSULTING Topic: NIDCRDESCRIPTION (provided by applicant): Quick-Set Material- Phase II Quick-Set material is proposed for vital pulp therapy and for non-vital endodontic use to make the clinical procedures shorter and more consistent, of benefit to the patient and clinician,and enhance the probability for a positive outcome. The new material should promote regeneration of the periodontal ligament and cemental tissues ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
A perfluorocarbon-based culture device for beta cell biology applications (Phase
SBC: Ophysio Inc. Topic: NIDDKABSTRACT Conventional culture vessels are not designed for physiological oxygen delivery. Both hyperoxia and hypoxia - commonly observed when culturing cells and tissues in regular plasticware- have been linked to reduced cellular function and death. An adequate means to provide oxygenation is also critical for stem cell applications in which the differentiation outcome is dependent on oxygen ten ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health